Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Price:
1 652.2
INR
-2.14%
Market Closed
Market Cap:
4T
INR
Balance Sheet
Balance Sheet Decomposition
Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd
| Current Assets | 460.7B |
| Cash & Short-Term Investments | 207.6B |
| Receivables | 129.9B |
| Other Current Assets | 123.2B |
| Non-Current Assets | 420.5B |
| Long-Term Investments | 68.1B |
| PP&E | 112.5B |
| Intangibles | 182.2B |
| Other Non-Current Assets | 57.7B |
Balance Sheet
Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd
Currency: INR
Millions
Annual
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
94 612
|
104 701
|
115 556
|
74 437
|
35 973
|
27 011
|
64 331
|
50 209
|
57 574
|
105 055
|
|
| Cash |
36 862
|
50 808
|
64 504
|
19 283
|
1 659
|
7 908
|
30 004
|
26 769
|
43 702
|
12 199
|
|
| Cash Equivalents |
57 750
|
53 893
|
51 052
|
55 154
|
34 314
|
19 103
|
34 328
|
23 439
|
13 872
|
92 857
|
|
| Short-Term Investments |
36 655
|
34 094
|
37 955
|
65 333
|
75 854
|
86 654
|
31 302
|
76 961
|
93 903
|
86 080
|
|
| Total Receivables |
63 000
|
80 541
|
84 761
|
82 191
|
95 553
|
99 408
|
93 248
|
121 851
|
129 598
|
132 557
|
|
| Accounts Receivables |
50 928
|
67 605
|
71 811
|
78 153
|
88 842
|
94 212
|
91 042
|
105 139
|
114 893
|
113 030
|
|
| Other Receivables |
12 072
|
12 936
|
12 950
|
4 038
|
6 711
|
5 196
|
2 205
|
16 712
|
14 705
|
19 527
|
|
| Inventory |
56 669
|
64 225
|
68 328
|
68 807
|
78 860
|
78 750
|
93 618
|
92 392
|
109 683
|
102 949
|
|
| Other Current Assets |
37 847
|
15 852
|
22 937
|
25 591
|
24 452
|
24 718
|
21 923
|
7 234
|
7 861
|
7 690
|
|
| Total Current Assets |
288 782
|
299 413
|
329 537
|
316 359
|
310 692
|
316 542
|
304 421
|
348 646
|
398 619
|
434 331
|
|
| PP&E Net |
85 318
|
87 866
|
100 601
|
105 935
|
109 382
|
112 263
|
111 715
|
111 689
|
113 537
|
113 001
|
|
| PP&E Gross |
85 318
|
87 866
|
100 601
|
105 935
|
109 382
|
112 263
|
111 715
|
111 689
|
113 537
|
113 001
|
|
| Accumulated Depreciation |
33 617
|
47 201
|
49 041
|
57 174
|
67 281
|
79 168
|
90 387
|
100 376
|
116 226
|
125 760
|
|
| Intangible Assets |
11 530
|
36 264
|
48 803
|
51 176
|
63 537
|
63 595
|
56 607
|
61 918
|
93 268
|
86 663
|
|
| Goodwill |
54 846
|
56 347
|
55 362
|
56 067
|
59 558
|
64 815
|
62 876
|
65 913
|
87 127
|
85 990
|
|
| Note Receivable |
13 069
|
16 799
|
31 948
|
59 715
|
37 365
|
39 385
|
38 218
|
26 225
|
24 488
|
24 855
|
|
| Long-Term Investments |
14 459
|
20 580
|
15 533
|
30 606
|
39 640
|
52 458
|
64 827
|
52 152
|
54 575
|
64 412
|
|
| Other Long-Term Assets |
33 596
|
38 034
|
32 319
|
25 305
|
26 764
|
33 467
|
38 004
|
31 536
|
35 821
|
45 378
|
|
| Other Assets |
54 846
|
56 347
|
55 362
|
56 067
|
59 558
|
64 815
|
62 876
|
65 913
|
87 127
|
85 990
|
|
| Total Assets |
501 601
N/A
|
555 303
+11%
|
614 102
+11%
|
645 164
+5%
|
646 938
+0%
|
682 525
+6%
|
676 667
-1%
|
698 078
+3%
|
807 436
+16%
|
854 629
+6%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
32 430
|
35 829
|
43 954
|
47 662
|
41 479
|
40 937
|
39 737
|
44 898
|
56 815
|
56 533
|
|
| Accrued Liabilities |
320
|
439
|
384
|
336
|
382
|
94
|
7 383
|
14 833
|
15 127
|
16 889
|
|
| Short-Term Debt |
62 127
|
52 061
|
66 549
|
79 797
|
83 708
|
55 494
|
24 449
|
4 685
|
59 583
|
28 444
|
|
| Current Portion of Long-Term Debt |
13 998
|
1 803
|
17 408
|
6 335
|
6 210
|
7 366
|
5 256
|
3 401
|
3 677
|
1 257
|
|
| Other Current Liabilities |
44 419
|
41 307
|
50 575
|
64 514
|
41 619
|
53 174
|
84 632
|
104 268
|
63 862
|
66 715
|
|
| Total Current Liabilities |
153 294
|
131 440
|
178 870
|
198 643
|
173 396
|
157 064
|
161 456
|
172 085
|
199 064
|
169 838
|
|
| Long-Term Debt |
13 598
|
31 103
|
14 361
|
17 721
|
15 226
|
20 289
|
8 981
|
4 817
|
5 599
|
3 036
|
|
| Deferred Income Tax |
751
|
1 194
|
3 286
|
2 190
|
1 043
|
581
|
445
|
319
|
317
|
1 551
|
|
| Minority Interest |
28 512
|
40 853
|
37 909
|
38 842
|
33 135
|
38 602
|
30 171
|
30 549
|
33 201
|
34 392
|
|
| Other Liabilities |
25 031
|
20 889
|
13 280
|
4 627
|
10 047
|
13 343
|
10 986
|
10 196
|
9 301
|
9 145
|
|
| Total Liabilities |
221 186
N/A
|
225 478
+2%
|
247 706
+10%
|
262 022
+6%
|
232 848
-11%
|
229 880
-1%
|
212 040
-8%
|
217 966
+3%
|
247 482
+14%
|
217 961
-12%
|
|
| Equity | |||||||||||
| Common Stock |
2 071
|
2 407
|
2 399
|
2 399
|
2 399
|
2 399
|
2 399
|
2 399
|
2 399
|
2 399
|
|
| Retained Earnings |
252 716
|
288 801
|
344 705
|
357 167
|
372 863
|
392 785
|
405 620
|
416 096
|
475 742
|
541 185
|
|
| Additional Paid In Capital |
18 369
|
18 592
|
11 895
|
11 929
|
11 933
|
11 874
|
11 874
|
11 874
|
11 874
|
11 874
|
|
| Unrealized Security Profit/Loss |
6 923
|
4 082
|
336
|
1 555
|
1 622
|
216
|
4 286
|
1 623
|
2 150
|
10 245
|
|
| Other Equity |
335
|
15 943
|
7 062
|
10 091
|
25 273
|
45 370
|
40 448
|
48 120
|
67 789
|
70 964
|
|
| Total Equity |
280 415
N/A
|
329 825
+18%
|
366 397
+11%
|
383 141
+5%
|
414 091
+8%
|
452 645
+9%
|
464 628
+3%
|
480 112
+3%
|
559 954
+17%
|
636 668
+14%
|
|
| Total Liabilities & Equity |
501 601
N/A
|
555 303
+11%
|
614 102
+11%
|
645 164
+5%
|
646 938
+0%
|
682 525
+6%
|
676 667
-1%
|
698 078
+3%
|
807 436
+16%
|
854 629
+6%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
2 071
|
2 407
|
2 399
|
2 399
|
2 399
|
2 399
|
2 399
|
2 399
|
2 399
|
2 399
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
